ConductScience.org, home
Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults
API referenceFor AI assistants

Trial · NCT06279871

Participant flow35

How many started, completed or left each group, period by period.

1 to 20 of 35

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDCohort A Group 1a: ARCT-2303+ Quadrivalent Influenza Vaccine (QIV) + Placebo408
Overall StudySTARTEDCohort A Group 2a: ARCT-2303 + Placebo + QIV406
Overall StudySTARTEDCohort A Group 3a: QIV + Placebo + ARCT-2303405
Overall StudySTARTEDCohort B Group 1b: ARCT-2303 + Adjuvanted QIV (aQIV) + Placebo99
Overall StudySTARTEDCohort B Group 2b: ARCT-2303 + Placebo + aQIV98
Overall StudySTARTEDCohort B Group 3b: aQIV + Placebo + ARCT-230398
Overall StudySTARTEDARCT-154-J01 (Historical Control)385
Overall StudyReceived Dose 1Cohort A Group 1a: ARCT-2303+ Quadrivalent Influenza Vaccine (QIV) + Placebo403
Overall StudyReceived Dose 1Cohort A Group 2a: ARCT-2303 + Placebo + QIV403
Overall StudyReceived Dose 1Cohort A Group 3a: QIV + Placebo + ARCT-2303398
Overall StudyReceived Dose 1Cohort B Group 1b: ARCT-2303 + Adjuvanted QIV (aQIV) + Placebo99
Overall StudyReceived Dose 1Cohort B Group 2b: ARCT-2303 + Placebo + aQIV98
Overall StudyReceived Dose 1Cohort B Group 3b: aQIV + Placebo + ARCT-230398
Overall StudyReceived Dose 1ARCT-154-J01 (Historical Control)385
Overall StudyReceived Dose 2Cohort A Group 1a: ARCT-2303+ Quadrivalent Influenza Vaccine (QIV) + Placebo393
Overall StudyReceived Dose 2Cohort A Group 2a: ARCT-2303 + Placebo + QIV394
Overall StudyReceived Dose 2Cohort A Group 3a: QIV + Placebo + ARCT-2303390
Overall StudyReceived Dose 2Cohort B Group 1b: ARCT-2303 + Adjuvanted QIV (aQIV) + Placebo95
Overall StudyReceived Dose 2Cohort B Group 2b: ARCT-2303 + Placebo + aQIV97
Overall StudyReceived Dose 2Cohort B Group 3b: aQIV + Placebo + ARCT-230396

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06279871/flow

API referenceFor AI assistants